FAM regimen: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
{{PAGENAME}} refers to a regimen consisting of [[fluorouracil]], [[doxorubicin|doxorubicin (adriamycin)]] and [[mitomycin]] used for the treatment of advanced-stage [[gastric cancer|gastric]] and [[pancreatic cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63395&ns=NCI_Thesaurus }}</ref> | {{PAGENAME}} refers to a regimen consisting of [[fluorouracil]], [[doxorubicin|doxorubicin (adriamycin)]] and [[mitomycin]] used for the treatment of advanced-stage [[gastric cancer|gastric]] and [[pancreatic cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63395&ns=NCI_Thesaurus }}</ref> | ||
==Regimen== | ==Regimen== |
Revision as of 15:25, 16 March 2015
WikiDoc Resources for FAM regimen |
Articles |
---|
Most recent articles on FAM regimen Most cited articles on FAM regimen |
Media |
Powerpoint slides on FAM regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on FAM regimen at Clinical Trials.gov Clinical Trials on FAM regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on FAM regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on FAM regimen Discussion groups on FAM regimen Patient Handouts on FAM regimen Directions to Hospitals Treating FAM regimen Risk calculators and risk factors for FAM regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for FAM regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:FAM Regimen; Fluorouracil-Adriamycin-Mitomycin Regimen
Overview
FAM regimen refers to a regimen consisting of fluorouracil, doxorubicin (adriamycin) and mitomycin used for the treatment of advanced-stage gastric and pancreatic cancer.[1]
Regimen
FFluorouracil
ADoxorubicin (adriamycin)
MMitomycin
Indications
- Advanced-stage gastric and pancreatic cancer.[2]